Seek Returns

TEM vs. WAT: Tempus AI vs. Waters Stock Comparison

How do Tempus AI (TEM) and Waters (WAT) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.

Company Profile

Tempus AI (TEM) and Waters (WAT) are both classified in the Life Sciences Tools & Services sub-industry within the broader Life Sciences Tools & Services industry, placing them in the closest GICS peer bucket.

Waters (WAT) carries decades of public-market history since November 17, 1995, while Tempus AI (TEM) listed on June 14, 2024 — long-window comparisons have far more historical data on the WAT side.

Company profile comparison for Tempus AI (TEM) and Waters (WAT)
Profile ItemTEMWAT
NameTempus AI Inc Class A Common StockWaters Corporation
Country/RegionUnited StatesUnited States
GICS SectorHealth CareHealth Care
GICS Industry GroupPharmaceuticals, Biotechnology & Life SciencesPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & ServicesLife Sciences Tools & Services
GICS Sub-IndustryLife Sciences Tools & ServicesLife Sciences Tools & Services
Market Capitalization13.87 billion USD44.93 billion USD
CurrencyUSDUSD
ExchangeNasdaqNYSE
Listing DateJune 14, 2024November 17, 1995
Security TypeCommon StockCommon Stock

Price Performance

Cumulative Growth

TEM
WAT
GSPC
Loading price history…
Tempus AI (TEM) vs. Waters (WAT), with S&P 500 (GSPC) for reference: Growth of a $10,000 investment over the past five years. Adjusted for dividends and splits.

Trailing Returns

Loading price history…
Trailing total returns for Tempus AI (TEM) and Waters (WAT). Returns over one year are annualized.

Calendar-Year Returns

Loading price history…
Calendar-year total returns for Tempus AI (TEM) and Waters (WAT). Each bar is that year's total return, measured year-end to year-end.

Performance Metrics

Price performance metrics for Tempus AI (TEM) and Waters (WAT)
MetricTEMWAT
Total Return (1Y)16.25%27.70%
Total Return (3Y, Annualized)--23.32%
Total Return (5Y, Annualized)--6.27%

Risk Profile

Drawdown History

TEM
WAT
GSPC
Loading price history…
Tempus AI (TEM) vs. Waters (WAT), with S&P 500 (GSPC) for reference: Drawdown from the running peak over the past five years. Each line shows the decline from its prior peak; 0% marks a new high.

Return Distribution

Loading price history…
Distribution of monthly total returns for Tempus AI (TEM) and Waters (WAT). Each bar is the share of months whose return fell in that 5% bucket.

Risk Metrics

Tempus AI (TEM) carries a highly aggressive beta of 3.34, indicating much higher sensitivity to broad-market moves, whereas Waters (WAT) is closer to market-like at 1.13 — a noticeable difference in market-sensitivity profile.

Risk profile metrics for Tempus AI (TEM) and Waters (WAT)
MetricTEMWAT
Volatility (1Y, Annualized)76.08%35.45%
Beta (5Y)3.341.13
Max Drawdown (5Y)-59.76%-36.47%
Avg. Volume (3M)7.20M816.72K

Risk-Adjusted Performance

Risk-Return Positioning

Loading chart…
TEM and WAT are plotted by 1-year volatility (risk) and 1-year return. The dashed Capital Allocation Line runs from the risk-free rate through the shared industry median.

Risk-Adjusted Metrics

Risk-adjusted metrics for Tempus AI (TEM) and Waters (WAT)
MetricTEMWAT
Sharpe Ratio (1Y)0.160.66
Sortino Ratio (1Y)0.260.98

Profitability

ROE (TTM)

Tempus AI (TEM) reports a negative ROE of -37.55%; negative ROE can reflect losses or negative shareholders’ equity, so it is harder to read as capital efficiency. Meanwhile Waters (WAT) reports 1.12%, ranking against industry peers normally.

TEM

Pharmaceuticals, Biotechnology & Life Sciences industry group

-37.55%

Max
109.18%
Q3
6.23%
Median
-26.66%
TEM
-37.55%
Q1
-64.05%
Min
-167.77%

WAT

Pharmaceuticals, Biotechnology & Life Sciences industry group

1.12%

Max
109.18%
Q3
6.23%
WAT
1.12%
Median
-26.66%
Q1
-64.05%
Min
-167.77%
Loading chart…
Tempus AI (TEM) vs. Waters (WAT): A comparison of their ROE against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Net Margin (TTM)

Tempus AI (TEM) reports a negative net margin of -12.54%, usually indicating a net loss over the period. Meanwhile Waters (WAT) reports 1.76%, ranking against industry peers normally.

TEM

Pharmaceuticals, Biotechnology & Life Sciences industry group

-12.54%

Max
18.05%
Q3
4.78%
Median
0.00%
Q1
-4.14%
TEM
-12.54%
Min
-17.05%

WAT

Pharmaceuticals, Biotechnology & Life Sciences industry group

1.76%

Max
18.05%
Q3
4.78%
WAT
1.76%
Median
0.00%
Q1
-4.14%
Min
-17.05%
Loading chart…
Tempus AI (TEM) vs. Waters (WAT): A comparison of their net margin against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Operating Margin (TTM)

Tempus AI (TEM) reports a negative operating margin of -13.82%, usually indicating that operating costs exceeded revenue at the operating-income line. Meanwhile Waters (WAT) reports 11.38%, ranking against industry peers normally.

TEM

Pharmaceuticals, Biotechnology & Life Sciences industry group

-13.82%

Max
83.12%
Q3
14.77%
Median
0.00%
TEM
-13.82%
Q1
-78.82%
Min
-207.40%

WAT

Pharmaceuticals, Biotechnology & Life Sciences industry group

11.38%

Max
83.12%
Q3
14.77%
WAT
11.38%
Median
0.00%
Q1
-78.82%
Min
-207.40%
Loading chart…
Tempus AI (TEM) vs. Waters (WAT): A comparison of their operating margin against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Profitability Metrics

Profitability metrics for Tempus AI (TEM) and Waters (WAT)
MetricTEMWAT
ROE (TTM)-37.55%1.12%
ROA (TTM)-7.36%2.36%
Net Margin (TTM)-12.54%1.76%
Operating Margin (TTM)-13.82%11.38%
Gross Margin (TTM)64.46%49.83%

Growth

Revenue Growth

Tempus AI (TEM) at 83.41% sits in the top revenue growth quartile, while Waters (WAT) at 6.99% is closer to the peer norm — faster top-line expansion for TEM.

Loading chart…
Tempus AI (TEM) vs. Waters (WAT): A comparison of their Revenue Growth across different time periods.

EPS Growth

Only one side can be read here: Waters (WAT) reports EPS growth of 0.47%, ranked against its industry; Tempus AI (TEM) has no EPS growth figure this period.

Loading chart…
Tempus AI (TEM) vs. Waters (WAT): A comparison of their EPS Growth across different time periods.

Growth Metrics

Growth metrics for Tempus AI (TEM) and Waters (WAT)
MetricTEMWAT
Revenue Growth (YoY)83.41%6.99%
Revenue Growth (3Y CAGR)58.29%2.12%
EPS Growth (YoY)--0.47%
EPS Growth (3Y CAGR)---2.84%

Financial Strength

Current Ratio (MRQ)

Short-term liquidity can only be read on one side of this pairing: Tempus AI (TEM) shows current ratio of 2.61 against its industry benchmark, while Waters (WAT) has no reading this period.

TEM

Pharmaceuticals, Biotechnology & Life Sciences industry group

2.61

Max
25.13
Q3
12.13
Median
5.52
TEM
2.61
Q1
2.47
Min
0.10

WAT

Pharmaceuticals, Biotechnology & Life Sciences industry group

--

Max
25.13
Q3
12.13
Median
5.52
Q1
2.47
Min
0.10
WAT
--
Loading chart…
Tempus AI (TEM) vs. Waters (WAT): WAT does not report current ratio, so it has no value marker; TEM is benchmarked against the Pharmaceuticals, Biotechnology & Life Sciences industry group.

Debt / Equity (MRQ)

Waters (WAT) at 0.34 is near its industry mid-range for debt-to-equity ratio, while Tempus AI (TEM) at 2.86 sits above its benchmark range, pointing to a heavier debt load relative to equity.

TEM

Pharmaceuticals, Biotechnology & Life Sciences industry group

2.86

TEM
2.86
Max
1.42
Q3
0.65
Median
0.15
Q1
0.02
Min
0.00

WAT

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.34

Max
1.42
Q3
0.65
WAT
0.34
Median
0.15
Q1
0.02
Min
0.00
Loading chart…
Tempus AI (TEM) vs. Waters (WAT): A comparison of their debt-to-equity ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Financial Strength Metrics

Financial strength metrics for Tempus AI (TEM) and Waters (WAT)
MetricTEMWAT
Current Ratio (MRQ)2.61--
Debt / Equity (MRQ)2.860.34
Net Debt / EBITDA--3.23

Dividends

Dividend Yield (TTM)

Neither Tempus AI (TEM) nor Waters (WAT) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.

TEM

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.00%

TEM
0.00%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%

WAT

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.00%

WAT
0.00%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%
Loading chart…
Tempus AI (TEM) vs. Waters (WAT): A comparison of their dividend yield against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Dividend Payout Ratio (TTM)

Neither Tempus AI (TEM) nor Waters (WAT) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.

TEM

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.00%

TEM
0.00%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%

WAT

Pharmaceuticals, Biotechnology & Life Sciences industry group

0.00%

WAT
0.00%
Max
0.00%
Q3
0.00%
Median
0.00%
Q1
0.00%
Min
0.00%
Loading chart…
Tempus AI (TEM) vs. Waters (WAT): A comparison of their payout ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Dividend Metrics

Dividend metrics for Tempus AI (TEM) and Waters (WAT)
MetricTEMWAT
Dividend Yield (TTM)0.00%0.00%
Dividend Payout Ratio (TTM)0.00%0.00%

Valuation

P/E Ratio (TTM)

An earnings multiple is available for just one side: Waters (WAT) trades at 191.46 times trailing earnings, ranked against its peers, while Tempus AI (TEM) has no P/E ratio this period.

TEM

Pharmaceuticals, Biotechnology & Life Sciences industry group

--

Max
85.34
Q3
43.46
Median
26.69
Q1
13.30
Min
0.07
TEM
--

WAT

Pharmaceuticals, Biotechnology & Life Sciences industry group

191.46

WAT
191.46
Max
85.34
Q3
43.46
Median
26.69
Q1
13.30
Min
0.07
Loading chart…
Tempus AI (TEM) vs. Waters (WAT): TEM does not report P/E ratio, so it has no value marker; WAT is benchmarked against the Pharmaceuticals, Biotechnology & Life Sciences industry group.

P/S Ratio (TTM)

On P/S ratio, both Tempus AI (TEM) at 9.19 and Waters (WAT) at 8.01 are priced roughly in line with their industries — neither looks cheap nor rich on a sales basis.

TEM

Pharmaceuticals, Biotechnology & Life Sciences industry group

9.19

Max
58.18
Q3
25.77
TEM
9.19
Median
7.30
Q1
3.01
Min
0.01

WAT

Pharmaceuticals, Biotechnology & Life Sciences industry group

8.01

Max
58.18
Q3
25.77
WAT
8.01
Median
7.30
Q1
3.01
Min
0.01
Loading chart…
Tempus AI (TEM) vs. Waters (WAT): A comparison of their P/S ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

P/B Ratio (MRQ)

Waters (WAT) at 2.94 sits near its industry’s typical P/B ratio, while Tempus AI (TEM) at 27.66 prices above its benchmark range — TEM looks rich relative to book.

TEM

Pharmaceuticals, Biotechnology & Life Sciences industry group

27.66

TEM
27.66
Max
13.53
Q3
6.54
Median
3.25
Q1
1.69
Min
-5.59

WAT

Pharmaceuticals, Biotechnology & Life Sciences industry group

2.94

Max
13.53
Q3
6.54
Median
3.25
WAT
2.94
Q1
1.69
Min
-5.59
Loading chart…
Tempus AI (TEM) vs. Waters (WAT): A comparison of their P/B ratio against the Pharmaceuticals, Biotechnology & Life Sciences industry group benchmark.

Valuation Metrics

Valuation metrics for Tempus AI (TEM) and Waters (WAT)
MetricTEMWAT
P/E Ratio (TTM)--191.46
P/S Ratio (TTM)9.198.01
P/B Ratio (MRQ)27.662.94
Free Cash Flow Yield (TTM)0.30%--